Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Uzay Gormus is active.

Publication


Featured researches published by Uzay Gormus.


Tumori | 2010

Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis

Zelal Erkisi; Ilhan Yaylim-Eraltan; Akif Turna; Uzay Gormus; Hakan Camlica; Turgay Isbir

AIMS AND BACKGROUNDnThe aim of this study was to investigate the relationship between EPHXI exon 3 Tyr113His and exon 4 His139Arg polymorphisms, predicted microsomal epoxide hydrolase (mEH) activity, and lung cancer development. mEH is a protective enzyme involved in oxidative defences against a number of environmental chemicals and pollutants, but it is also responsible for the xenobiotic activation of carcinogens.nnnMETHODSnWe investigated the two polymorphisms of the mEH gene (EPHX1) in 58 lung cancer patients and 41 controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).nnnRESULTSnThe exon 3 Tyr113His polymorphism was associated with lung cancer (P < 0.001). The frequency of the His113His homozygote genotype in exon 3 was significantly increased in patients compared with controls (P < 0.001). In contrast, there was no significant difference in exon 4 polymorphisms between patients and controls. When the exon 3 and 4 polymorphisms were considered together, the combined EPHX1 His113His113/His139His139 genotype (very low predicted enzyme activity) was found to be associated with an increased risk of lung cancer (P = 0.044, OR = 3.063, CI = 0.932-10.069). We observed that patients with T3 + T4 tumors had an approximately 3-fold higher risk of the Tyr113/His113 genotype than patients with T1 + T2 tumors. Lung cancer patients carrying a heterozygote Tyr113/His 113 genotype had a 2-fold increased risk of lymph node metastases (P = 0.051).nnnCONCLUSIONnThese findings suggest that the exon 3 Tyr113His and exon 4 His139Arg polymorphisms of EPHXI may be associated with a increased risk of lung cancer and a worse prognosis.


Cell Biochemistry and Function | 2008

The relationship of oral disturbances of diabetes mellitus patients with paraoxonase gene polymorphisms.

Meral Ünür; Erdinç Demirez; Bedia Agachan; Uzay Gormus; Arzu Ergen; Burak Dalan; Turgay Isbir

Diabetes Mellitus (DM) is a multisystemic disorder with serious complications and these patients may also have serious problems with their oral cavity probably because of the microangiopathic and neuropathic complications. In diabetic patients, there may be several problems of the oral cavity such as gingivitis, periodontitis, candidiasis, glossitis, oral ulcerations, loss of taste sensations, opportunistic infections and several other conditions dependent on these. One of the recent theories about complications in DM is the contribution of reactive oxygen radicals. Paraoxonase (PON1) is an enzyme that is synthesized in liver and having the capability of hydrolasing the active metabolite of an insectisid, parathion. Previously it was shown that there are two polymorphic areas on the PON1 gene: one causing a Leuu2009→u2009Met substitution at 55th position, the other causing Glnu2009→u2009Arg at the 192nd position. We investigated the differences in PON activities related to the oral lesions in Type 2 diabetics and control subjects to see their relationships with PON1 activity levels and the two main gene polymorphisms of PON1 genes, PON1 192 and PON1 55. We had 51 patients and 53 healthy subjects used in the study. PON activity was significantly decreased in Type 2 DM group compared to the control group. Neither PON1 192 nor PON1 55 genotypes had any differential effect on PON1 enzyme activity levels in either group. However, we found that PON1 55 M allele carriers had greater risk for general periodontal and/or gingival problems. Copyright


Archive | 2012

PCR-RFLP and Real-Time PCR Techniques in Molecular Cancer Investigations

Uzay Gormus; Nur Selvi; Ilhan Yaylim-Eraltan

The polymerase chain reaction (PCR) is a rapid scientific method for generating a 106-107fold increase in the number of copies of discrete DNA or RNA sequences (Boehm,1989; Imboden et al,1993). The use of PCR technology has greatly increased the ability to study on genetic material. PCR is a rapid and reliable molecular biology technique that allows quick replication of mainly DNA, the starting material can be a single molecule of rRNA or mRNA. It was developed by Kary Mullis in 1983, and he was awarded the Nobel Prize in 1993. PCR method is useful in situations of limited amount of DNA sample as in forensics, prenatal testing, because it amplifies a single or a few copies of DNA creating millions of copies of the region(1). The ability to quickly produce large quantities of genetic material has enabled significant scientific advances including DNA fingerprinting and sequencing of the human genome. As PCR technology allows taking specimen of genetic material even from just one cell, copy its genetic material several times, this facilitates genetic studies. Currently, besides research purposes, PCR technology is heavily used in diagnosis and patient management especially for viral diseases such as AIDS and hepatitis. Other than detection of infectious organisms, this technology is also useful for determination of genetic polymorphisms or mutations of individuals (Stahlberg,2011).


Anticancer Research | 2009

Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.

Bedia Agachan; Ozlem Kucukhuseyin; Pinar Aksoy; Akif Turna; Ilhan Yaylim; Uzay Gormus; Arzu Ergen; Umit Zeybek; Burak Dalan; Turgay Isbir


Anticancer Research | 2007

Fas-1377A/G and FasL-844 T/C Gene Polymorphisms and Epithelial Ovarian Cancer

Uzay Gormus; Arzu Ergen; Hulya Yilmaz; Burak Dalan; Sinan Berkman; Turgay Isbir


Anticancer Research | 2007

Investigation of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism in Prostate Cancer

H. Arzu Ergen; Uzay Gormus; Fehmi Narter; Umit Zeybek; Sibel Bulgurcuoglu; Turgay Isbir


in Vivo | 2007

Fas-1377 A/G Polymorphism in Lung Cancer

Uzay Gormus; Arzu Ergen; Ilhan Yaylim-Eraltan; Hulya Yilmaz; Akif Turna; Nilüfer Bozkurt; Turgay Isbir


in Vivo | 2009

Breast Cancer and Cyclin D1 Gene Polymorphism in Turkish Women

Ilhan Yaylim-Eraltan; Arzu Ergen; Uzay Gormus; Soykan Arikan; Seden Küçücük; Orhan Sahin; Nilüfer Yigit; Yemliha Yildiz; Turgay Isbir


in Vivo | 2009

Associations of Lipoprotein Lipase S447X and Apolipoprotein E Genotypes with Low-density Lipoprotein Subfractions in Turkish Patients with Coronary Artery Disease

Hulya Yilmaz Aydogan; Selim Isbir; Ozlem Kurnaz; Uzay Gormus; Turgay Isbir


Cell Biochemistry and Function | 2008

The effect of NQO1 polymorphism on the inflammatory response in cardiopulmonary bypass.

C. Selim Isbir; Arzu Ergen; Atike Tekeli; Umit Zeybek; Uzay Gormus

Collaboration


Dive into the Uzay Gormus's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge